BATON ROUGE, Louisiana — Louisiana is moving forward with a criminal case against an out-of-state doctor accused of sending abortion medication to a patient within the state, according to documents filed recently in court.
The US Supreme Court’s involvement relates to a California physician implicated in a case from 2022. This charge marks an uncommon instance of enforcement of state abortion restrictions that have been in place since the reversal of Roe v. Wade.
This situation is part of a broader legal confrontation between liberal and conservative states regarding telehealth abortion prescriptions and whether medications can be mailed to patients.
Abortion pills have become the most frequently utilized method for abortions across the United States, and reports suggest they are a significant factor in the rising number of procedures last year.
A Louisiana woman says she was compelled to use abortion pills
In a filing made on September 19, Louisiana announced that it had issued a warrant for a California-based doctor alleged to have provided medication to a woman in Louisiana in 2023.
The woman, identified as Rosalie Marchezic, along with the state attorney general, is seeking to join a lawsuit aimed at preventing telehealth prescriptions for Mifepristone, which is one of two medications used in medical abortions.
In her court statement, Marchezic explained that her boyfriend utilized her email to order the pills from Dr. Remy Coetau, sending her $150 to facilitate the transaction. She claimed to have had no direct communication with the doctor.
She expressed reluctance about taking the pills, saying that the trauma from her experience “still bothers me.” Marchezic argued that if telehealth prescriptions were restricted, her situation wouldn’t have occurred.
The claims arise from perspectives held by anti-abortion advocates. They argue that prescribing abortion pills via remote consultations and mailing them risks coercive situations for women.
“Rosalie stands as a brave representative for many women who have endured the illegal and unethical actions of these providers,” remarked Louisiana Attorney General Liz Murrill in a statement.
Doctors are also facing lawsuits in Texas
Murrill’s office has yet to respond to inquiries regarding the specific allegations against Coetau or the timing of the warrant’s issuance. According to state law, doctors can be prosecuted for providing abortions at any stage of pregnancy.
Coetau is also facing a civil lawsuit in federal court from a Texas man who alleges that Coetau unlawfully provided abortion pills to his girlfriend.
Attempts to reach Coetau for comment via email and phone were unsuccessful.
This legal battle involves not only ongoing investigations in Louisiana but also civil actions in Texas against New York doctor Margaret Carpenter. New York officials are refusing to extradite Carpenter to Louisiana and have declined to allow Texas’s Attorney General Ken Paxton to enforce a civil ruling against her.
In one Louisiana case, it was reported that a minor’s mother ordered abortion medication, which led to her arrest; she is out on bail after pleading not guilty.
New York is citing laws designed to protect healthcare providers who issue abortion-related prescriptions—even in states where such services are banned.
New York and California are among eight states that have protective laws in place, according to data from the Guttmacher Institute, a research entity backing abortion rights.
The Telehealth Abortion Coalition asserted that California Governor Gavin Newsom was expected to support the state’s protective measures in upcoming legal matters.
Murrill indicated that Louisiana was committed to pursuing legal actions aimed at safeguarding residents against any unlawful enterprises.
The legal and political battle over abortion drugs is expanding
The legal action against Coetau in Louisiana is part of a broader initiative associated with a lawsuit filed last year by the Republican attorney generals of Louisiana, Texas, and Florida, seeking to challenge the federal approval of Mifepristone.
Recently, Louisiana and Texas have enacted new laws targeting out-of-state abortion drug providers.
In Louisiana, patients who receive abortions can sue their healthcare providers, while Texas law broadens this to allow anyone to take legal action against those prescribing the pills within the state.
Health Secretary Robert F. Kennedy Jr. and Food and Drug Director Marty McCurry have stated that they are reviewing the safety and effectiveness of Mifepristone.
Since its approval in 2000, drug-induced abortions have been a viable option in the United States.
This week, 19 Democratic state attorney generals emphasized that Mifepristone is safe while expressing concerns about the FDA’s review.
The Telehealth Abortion Coalition reiterated that these medications are safe and represent an essential component of women’s healthcare.
In response to Louisiana’s actions against Coetau, an organization co-founded by Carpenter characterized the legal pursuit as “extreme” and as an intimidation tactic against healthcare providers.
Murrill characterized the unlawful distribution of abortion medication as “dangerous” and pledged to apply “all available legal resources” to enforce the state’s abortion regulations.
